1. Section
     IPS Medication Summary Section (2.16.840.1.113883.10.22.3.1)
    1. Entry
       IPS Body Author (2.16.840.1.113883.10.22.4.14)
      1. Entry
         IPS CDA Device (2.16.840.1.113883.10.22.9.2)
    2. Entry
       CDA Informant (Body) (2.16.840.1.113883.10.12.319)
      1. *
         CDA AssignedEntity (2.16.840.1.113883.10.12.153)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      2. Entry
         CDA RelatedEntity (2.16.840.1.113883.10.12.316)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
    3. Entry
       IPS Medication Statement (2.16.840.1.113883.10.22.4.4)
      1. Entry
         UV Use Period (2.16.840.1.113883.10.21.9.1)
      2. Entry
         IPS Medication Information (detail) (2.16.840.1.113883.10.22.4.2)
        1. Entry
           IPS Manufactured Material (2.16.840.1.113883.10.22.4.3)
      3. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      4. Entry
         UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)
    4. Section
       IPS Translation Section (2.16.840.1.113883.10.22.3.15)